Array Biopharma, Inc. (ARRY) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $4.20 --0%
Revenue Growth %: -16.2%
Financial Fact:
Comprehensive loss: -28.6M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: -16.2%
Financial Fact:
Comprehensive loss: -28.6M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q4 EPS of ($0.22), $0.01 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $6 million versus the consensus estimate of $8.1 million.
For earnings history and earnings-related data on Array Biopharma, Inc. (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- Oscar Health Inc (OSCR) PT Raised to $48 at Piper Sandler
- The Fed is hiking. Why isn't UBS worried about stocks?
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
